The artificial lung (AL) technology is one of the membrane-based artificial organs that partly
augments lung functions, ie blood oxygenation and CO 2 removal. It is generally employed …

Extracorporeal membrane oxygenation (ECMO) is an invasive and last-resort treatment for
circulatory and respiratory failure. Prolonged ECMO support can disrupt the coagulation and …

Biomedical gas exchange membranes used for blood oxygenation, including extracorporeal
membrane oxygenators (ECMO) and artificial lung technology, have suffered from the …

Biomedical devices are prone to blood clot formation (thrombosis), and liquid‐infused
surfaces (LIS) are effective in reducing the thrombotic response. However, the mechanisms …

Medical devices that require substantial contact between blood and a foreign surface would
be dramatically safer if constructed from materials that prevent clot formation and …

Liquid infused surfaces (LIS) hold remarkable potential in anticoagulation. However, liquid
loss of LIS in the bloodstream remains a challenge toward its clinical application. Here …

Background Clinical translation of the extracorporeal artificial placenta (AP) is impeded by
the high risk for intracranial hemorrhage in extremely premature newborns. The Nitric Oxide …

Tethered‐liquid perfluorocarbon (TLP) coatings show promise for blood‐contacting medical
device applications to reduce blood adhesion and delay thrombosis. However, their …

Despite the numerous advantages demonstrated by microfluidic mixing for RNA-loaded lipid
nanoparticle (RNA-LNP) production over bulk methods, such as precise size control …

Perfluorocarbons (PFCs) are organic liquids derived from hydrocarbons in which some of
the hydrogen atoms have been replaced by fluorine atoms. They are chemically and …